The Health of the Public Program at the University of Washington: A New Role for Academic Medical Centers

1991 ◽  
Vol 66 (9) ◽  
pp. 499-505 ◽  
Author(s):  
HAROLD I. GOLDBERG ◽  
DIANE P. MARTIN ◽  
DALE B. CHRISTENSEN ◽  
WILLIAM E. NEIGHBOR ◽  
THOMAS S. INUI ◽  
...  
2004 ◽  
Vol 52 (4) ◽  
pp. 242-245

The American Federation for Medical Research (AFMR) will present a series of articles that address the challenges faced by academic medical centers and other institutions in developing medical scientists (see the accompanying introduction to the series on page 241). The goal of this series is to assist leaders at academic medical centers in addressing the challenges for training the next generation of health care investigators. In addition, we hope to educate junior investigators and trainees on the many issues that their facilitators and mentors face in developing adequate programs for training and career development.Our first part of this series is an interview with Robert W. Schrier, MD. Dr. Schrier is a professor of medicine and was chairman of the Department of Medicine at the University of Colorado School of Medicine for 26 years and head of the Division of Renal Diseases and Hypertension for 20 years. Dr. Schrier's research accomplishments are enormous. He has had continuous funding for 35 years and has authored over 800 scientific papers and edited 45 books in renal medicine, geriatrics, drug use, and kidney disease. He is an acknowledged leader in academic medicine, as evidenced by his election to the Institute of Medicine of the National Academy of Sciences and presidencies of the Association of American Physicians, the American Society of Nephrology, the National Kidney Foundation, and the International Society of Nephrology. Dr. Schrier is a master of the American College of Physicians and an honorary fellow of the Royal College of Physicians. In addition, he has received the highest awards of several national and international organizations.However, it is not only the personal accomplishments of Dr. Schrier that led to his selection to take part in this series. Although those personal accomplishments are incredible, his work as a department chair, division chief, and research mentor may be greater. During Dr. Schrier's 26 years as chair of the Department of Medicine at the University of Colorado, the full-time faculty increased from approximately 75 to 500. The annual research grants by the department's full-time faculty rose from approximately $3 to $100 million, including the faculties' contributions to the General Clinical Research and Cancer Centers. The housestaff and fellow training programs also became nationally prominent. Thirty endowed research chairs between $1.5 and $2.0 million each were established. Clearly, he is a visionary who can speak to the challenges facing the young medical scientists and their mentors today.Dr. Schrier's responses to a series of questions follow.


2021 ◽  
pp. 161-165
Author(s):  
Corrado Cuccurullo ◽  
Luca D’Aniello ◽  
Massimo Aria ◽  
Maria Spano

The Italian public-owned Academic Medical Centers (AMCs) are hospitals where the activities of scientific research, teaching, and patients care are fully integrated. AMCs have an enormous impact on society and country health. Recently, policymakers and practitioners give more and more great importance to the AMCs’ scientific activity for both welfare and national competitivity. The scientific production and its impact on the research community could be obviously affected by different factors related to the structural and operational characteristics of each AMC. Healthcare institutions could be different for the typology of services that they offer, their geolocation, the presence/absence of Emergency Departments, the number of employees, and so forth. In this sense, our study aims to investigate and determine which are the possible factors impacting the research productivity of AMCs. We develop a model to assess the academic value of AMCs by taking into account these factors and how they are related to healthcare performance, measured in terms of scientific production (e.g. scientific publications) and impact on the research field (e.g. citations). To face this issue, for each of the public AMCs we collect data about research productivity from bibliographic indexing databases (e.g. Web of Science, PubMed) and we retrieve structural information mainly from their official websites. This work has been partially financed by the research project “Leading Change in Academic Medical Centers”, funded by the competitive call for projects V:ALERE 2019. The project aims to provide evidence, advice, and remarks to help the agents of the public health system to address the many challenges that they face.


2011 ◽  
Vol 77 (10) ◽  
pp. 1300-1304 ◽  
Author(s):  
Joseph C. Carmichael ◽  
Hossein Masoomi ◽  
Steven Mills ◽  
Michael J. Stamos ◽  
Ninh T. Nguyen

Use of laparoscopy in colorectal cancer surgery is still limited. The aim of this study was to determine the rate of use of laparoscopic colorectal surgery for cancer at academic medical centers and to evaluate if the site of surgery influences the rate of use. Clinical data of patients who underwent laparoscopic or open colon and rectal resections for cancer from 2007 to 2009 were obtained from the University HealthSystem Consortium database. Data concerning rate of laparoscopy, length of stay, morbidity, and risk-adjusted mortality were obtained. During the 36-month study period, 22,780 operations were performed. The overall rate for use of laparoscopy was 14.8 per cent. Laparoscopy was most often used for total colectomy (22.6%), sigmoid colectomy (17.3%), cecectomy (17.1%), and right hemicolectomy (17.0%). Laparoscopy was most infrequently used for abdominoperineal resection (8.0%), transverse colectomy (10.0%), and left hemicolectomy (13.1%). Length of stay for laparoscopic colon and rectal procedures was 3.2 days shorter than for open surgery. Although the benefits of laparoscopic colorectal surgery for cancer have been demonstrated, the use of laparoscopy for colorectal resection remains under 20 per cent for colon cancer and under 10 per cent for rectal cancer. Further studies are needed to determine the factors limiting the use of laparoscopy in colorectal surgery.


2019 ◽  
Vol 28 (3) ◽  
pp. 468-475 ◽  
Author(s):  
MARK YARBOROUGH ◽  
TIMOTHY HOUK ◽  
SARAH TINKER PERRAULT ◽  
YAEL SCHENKER ◽  
RICHARD R. SHARP

Abstract:Academic Medical Centers (AMCs) offer patient care and perform research. Increasingly, AMCs advertise to the public in order to garner income that can support these dual missions. In what follows, we raise concerns about the ways that advertising blurs important distinctions between them. Such blurring is detrimental to AMC efforts to fulfill critically important ethical responsibilities pertaining both to science communication and clinical research, because marketing campaigns can employ hype that weakens research integrity and contributes to therapeutic misconception and misestimation, undermining the informed consent process that is essential to the ethical conduct of research. We offer ethical analysis of common advertising practices that justify these concerns. We also suggest the need for a deliberative body convened by the Association of American Medical Colleges and others to develop a set of voluntary guidelines that AMCs can use to avoid in the future, the problems found in many current AMC advertising practices.


PEDIATRICS ◽  
1995 ◽  
Vol 96 (6) ◽  
pp. 1143-1145
Author(s):  
Laurel K. Leslie

On January 18, 1995, the University of California convened a special meeting to discuss the business operations of its five academic medical centers in San Francisco, Sacramento, San Diego, Los Angeles, and Irvine. Because of the rapid developments occurring in the maturing and competitive managed care market in California, the academic medical centers are facing unprecedented financial pressures. Charles Townsend, of the accounting firm KPMG Peat Marwick, stated that the medical centers' staff would need to be cut by at least 2500 full-time equivalents, including physicians and nurses, by the year 1999. William Kerr, Director of the University of California San Francisco Medical Center, forecasted a comprehensive restructuring and streamlining of services. Jordan Cohen, president of the Association of American Medical Colleges, described the challenges facing these five academic medical centers and others like them as "truly seismic."1 The rise of managed care medical systems during the last 5 years has led many researchers to question whether the academic medical center will survive in its current state.2-6 Market forces are changing the provision of medical care at an extremely fast pace. By 1998, an estimated 60% of people living in US cities will be covered by managed care health plans. Fewer hospital admissions, shorter hospital stays, and decreased reimbursements associated with managed care have decreased hospitals' operating gains. Academic medical centers, such as those in California, are facing pressure to lower health care delivery costs. The probable decreases in Medicare and research funds under the current Congress also threaten the financial revenues of academic medical centers.


2012 ◽  
Vol 33 (8) ◽  
pp. 782-789 ◽  
Author(s):  
Michael Z. David ◽  
Sofia Medvedev ◽  
Samuel F. Hohmann ◽  
Bernard Ewigman ◽  
Robert S. Daum

Objective.The incidence of invasive methicillin-resistant Staphylococcus aureus (MRSA) infections in the United States decreased during 2005–2008, but noninvasive community-associated MRSA (CA-MRSA) infections also frequently lead to hospitalization. We estimated the incidence of all MRSA infections among inpatients at US academic medical centers (AMCs) per 1,000 admissions during 2003–2008.Design.Retrospective cohort study.Setting and Participants.Hospitalized patients at 90% of nonprofit US AMCs during 2003–2008.Methods.Administrative data on MRSA infections from a hospital discharge database (University HealthSystem Consortium [UHC]) were adjusted for underreporting of the MRSA V09.0 International Classification of Diseases, Ninth Revision, Clinical Modification code and validated using chart reviews for patients with known MRSA infections in 2004–2005, 2006, and 2007.Results.The mean sensitivity of administrative data for MRSA infections at the University of Chicago Medical Center in three 12-month periods during 2004–2007 was 59.1%. On the basis of estimates of billing data sensitivity from the literature and the University of Chicago Medical Center, the number of MRSA infections per 1,000 hospital discharges at US AMCs increased from 20.9 (range, 11.1–47.7) in 2003 to 41.7 (range, 21.9–94.0) in 2008. At the University of Chicago Medical Center, among infections cultured more than 3 days prior to hospital discharge, CA-MRSA infections were more likely to be captured in the UHC billing-derived data than were healthcare-associated MRSA infections.Conclusions.The number of hospital admissions for any MRSA infection per 1,000 hospital admissions overall increased during 2003–2008. Use of unadjusted administrative hospital discharge data or surveillance for invasive disease far underestimates the number of MRSA infections among hospitalized patients.


Sign in / Sign up

Export Citation Format

Share Document